MENU
+Compare
ZYXI
Stock ticker: NASDAQ
AS OF
Apr 23, 04:59 PM (EDT)
Price
$2.44
Change
+$0.18 (+7.96%)
Capitalization
397.95M

ZYXI stock forecast, quote, news & analysis

Zynex Inc is engaged in the manufacturing and marketing of medical devices... Show more

ZYXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for ZYXI with price predictions
Apr 22, 2025

ZYXI's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for ZYXI turned positive on April 01, 2025. Looking at past instances where ZYXI's MACD turned positive, the stock continued to rise in of 57 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ZYXI's RSI Indicator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where ZYXI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 22, 2025. You may want to consider a long position or call options on ZYXI as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZYXI advanced for three days, in of 265 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZYXI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ZYXI entered a downward trend on April 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.718) is normal, around the industry mean (7.892). P/E Ratio (46.296) is within average values for comparable stocks, (29.460). ZYXI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (4.521). ZYXI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.032). P/S Ratio (2.451) is also within normal values, averaging (35.215).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ZYXI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZYXI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

A.I.Advisor
published Dividends

ZYXI paid dividends on January 21, 2022

Zynex ZYXI Stock Dividends
А quarterly dividend of $0.11 per share was paid with a record date of January 21, 2022, and an ex-dividend date of January 05, 2022. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 10.22B. The market cap for tickers in the group ranges from 494.39K to 70.55B. MCK holds the highest valuation in this group at 70.55B. The lowest valued company is SNYR at 494.39K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was 4%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -11%. AHG experienced the highest price growth at 42%, while MEPDF experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was -89%. For the same stocks of the Industry, the average monthly volume growth was -61% and the average quarterly volume growth was 34%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 59
Price Growth Rating: 58
SMR Rating: 77
Profit Risk Rating: 80
Seasonality Score: 3 (-100 ... +100)
View a ticker or compare two or three
ZYXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a distributor of medical devices

Industry MedicalDistributors

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
9555 Maroon Circle
Phone
+1 303 703-4906
Employees
1100
Web
https://www.zynex.com